1 year return (CAGR)
139.63%
Lexaria Bioscience Corp Exchange (NASDAQ, USD)
LEXX
3.23
+0.01 (+0.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
52.62%
5 year return (CAGR)
-12.23%
10 year return (CAGR)
-2.58%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.35M
Price/Sales
27.56
Ent value
2.31M
Price/Book
1.23
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-14.16%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.31 |
| Daily high | 3.34 |
| Daily low | 3.11 |
| Daily Volume | 14K |
| All-time high | 646.61 |
| 1y analyst estimate | 52.50 |
| Beta | 0.37 |
| EPS (TTM) | -4.68 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 14 Apr 2026 |
Downside potential
Loading...
Downside potential data
| LEXX | S&P500 | |
| Current price drop from All-time high | -99.50% | -1.29% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 21 Nov 2012 | 9 Mar 2009 |
| Avg drop from high | -93.06% | -10.68% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 4083 days | 1805 days |
News
